Research
Gelatin is a versatile natural material. To tailor its properties specifically to the requirements of various applications in medicine, diagnostics, and cosmetics, the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed a toolbox for chemical functionalization. With the help of automated processes, the modifications can now be scaled under defined conditions, and reproducible […]
read more
AI agent MIRA supports clinical workflows in electronic health records as a co-pilot
Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology and University Hospital Dresden present the next stage of medical AI in a new study published in Nature. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and Heidelberg University Hospital were also involved. The team led […]
read more
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
ZURICH, SWITZERLAND – June 10, 2026 — VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, today announced that its previously announced business combination (“Business Combination”) with Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), a special purpose acquisition company sponsored by Cantor Fitzgerald & Co., Voyager Acquisition Sponsor Holdco LLC, and Odeon Capital Group LLC, was […]
read more
Complications after liver transplantation and leukemic niches: Heidelberg Faculty of Medicine honors outstanding early-career researchers
The Heidelberg Faculty of Medicine at Heidelberg University presented the Anita and Friedrich Reutner Prize for Medical Research and the Hoffmann-Klose Prize for an outstanding Clinician Scientist project at this year’s Faculty Day – an event bringing together students, researchers, and teaching staff. The award recipients, Christine Zhang-Hagenlocher and Kristina Müller, are early-career physician-scientists From […]
read more
AI Diagnoses Brain Tumors in Minutes Instead of Weeks
Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system identifies more than 100 molecular subtypes of central nervous system tumors, delivers results within minutes, and could accelerate the diagnosis of brain tumors worldwide. Tumors of the brain […]
read more
CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice
Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]
read more
Fat hack protects against cell death
In response to stress or damage, cells undergo senescence and stop dividing. However, if senescent cells accumulate in tissues over the long term, chronic inflammation occurs and the risk of cancer increases. Researchers at the German Cancer Research Center (DKFZ) have now discovered a previously unknown mechanism by which senescent cells protect themselves from oxidative […]
read more
Potential Biomarker for Personalized Leukemia Therapy Identified
Researchers at Heidelberg Faculty of Medicine at Heidelberg University, in collaboration with partners from 29 German study centers, have found evidence of a potential biomarker for personalized therapy of acute myeloid leukemia (AML) in a Phase II study. Analyses showed that certain patients could benefit from additional treatment with the drug Motixafortide in addition to […]
read more
PEPperPRINT Secures State Funding for Development of GlycoPlex Glycopeptide Array Platform
Heidelberg, 15th of May 2026 – PEPperPRINT GmbH has successfully secured additional research and development funding from the innovation funding program “Invest BW” of the German state of Baden-Württemberg for the development of its new GlycoPlex platform, a high-throughput technology for disease-relevant glycopeptide analyses. The funded project, titled “GlycoPlex – High-Throughput Platform for Disease-Relevant Glycopeptide Analyses”, […]
read more
